Accumulating evidence has shown that abnormal cleavage of APP is a central process in the pathological mechanisms of Alzheimer’s disease (AD) (27–29), and the Wnt/β-catenin pathway is dysfunctional in AD brains (30–32). The gene discussed is APP; the disease is Alzheimer disease.